Ebola Virus Disease (EVD) remains one of the most challenging medical\nproblems in the history of modern health. Known for its sudden onset and\ndevastating effects, Ebola is not merely a typical infection; it is a\nsystemic assault that cripples the human body\u2019s defenses.<\/p>\n
The death rate or Case Fatality Rate (CFR) of Ebola is among the\nhighest in medical science. Based on historical data from the World\nHealth Organization (WHO), the average mortality rate sits around 50%.\nYet this figure fluctuates depending on outbreak location, virus strain,\nand the speed of medical intervention.<\/p>\n
In certain outbreaks in remote areas with limited access to\nhealthcare, mortality has climbed to 90%. By comparison, this mortality\nrate far surpasses other infectious diseases such as COVID-19 or\nseasonal influenza, placing Ebola in the category of high-level\npathogens (Biosafety Level 4).<\/p>\n
Not all Ebola viruses have the same virulence. There are five Ebola\nvirus species, with three of them having caused large outbreaks in\nhumans:<\/p>\n
The difficulty in curing Ebola stems from the way this virus\ninteracts with human biology. Here are the main reasons:<\/p>\n
Ebola is a cunning deceiver. Once it enters the body, the virus\ntargets key immune system cells, particularly dendritic cells and\nmacrophages. These cells should act as scouts, signaling lymphocytes (T\ncells and B cells) to begin antibody production. By disabling these\nscouts, the virus can replicate massively without detection by the\nbody\u2019s defence system in the early, crucial phase.<\/p>\n
When the immune system finally recognises the virus, the response is\noften late and excessive. The body releases inflammatory signalling\nmolecules (cytokines) in uncontrolled quantities. Instead of killing the\nvirus, this \u2018cytokine storm\u2019 damages blood vessels and body tissues,\ncausing fluid leakage and organ failure.<\/p>\n
The Ebola virus possesses the ability to replicate at extraordinary\nspeed. In a short time, the number of viral particles in the blood\n(viral load) can become very high, overwhelming vital organs such as the\nliver, spleen, and kidneys before drugs or the immune system can\nreact.<\/p>\n
Ebola causes necrosis (tissue death) in the liver. Since the liver is\nresponsible for producing blood clotting factors, its damage triggers\ninternal bleeding that is difficult to stop.<\/p>\n
To date, there is no antiviral drug that can instantly shut down the\nEbola virus once infection has reached advanced stages. Some major\nobstacles include:<\/p>\n
Although difficult, that does not mean Ebola cannot be treated. The\nkey to improving survival is early supportive care. Aggressive\nelectrolyte and fluid replacement (rehydration) can help the body endure\nlong enough for the immune system to produce antibodies to combat the\nvirus.<\/p>\n
Additionally, the use of monoclonal antibodies (such as Inmazeb and\nEbanga) has shown highly promising results in clinical trials,\nsignificantly reducing mortality when given soon after symptoms\nappear.<\/p>\n
The high mortality rate of Ebola and the difficulty of cure are due\nto the virus\u2019s ability to hijack the immune system and disrupt the\nintegrity of the human vascular system. The success in fighting Ebola\noutbreaks relies heavily on rapid detection and the readiness of medical\ninfrastructure to provide antibody therapy and intensive rehydration\nbefore organ damage becomes permanent. (H-3)<\/p>\n
A comprehensive guide to Ebola disease, transmission, high mortality,\nand pandemic potential according to global health experts.<\/p>\n
Complete information on the Ebola vaccines status (Ervebo &\nZabdeno) and analysis of the risk of Ebola entering Indonesia based on\nglobal health protocols.<\/p>\n
WHO declared Ebola outbreaks in Bundibugyo in Congo and Uganda a\nglobal health emergency after claiming nearly 100 lives in May 2026.<\/p>\n
DIREKTUR pascasarjana Universitas YARSI Tjandra Yoga Aditama assesses\nthat the Ebola outbreak currently occurring in Africa requires\nstrengthened international cooperation.<\/p>\n
US President Donald Trump admitted to worrying about the Ebola\noutbreak in Congo after an American doctor contracted the virus. The US\nimmediately blocked foreign travellers.<\/p>", "url": "https:\/\/jawawa.id\/newsitem\/ebolas-mortality-rate-and-the-medical-reasons-why-this-virus-is-difficult-to-cure-1779546217", "image": "" }, "sponsor": "Okusi Associates", "sponsor_url": "https:\/\/okusiassociates.com" }